1. Service Overview
1.1.
Market
Definition
1.2.
Scope
of the Market
1.2.1.
Markets
Covered
1.2.2.
Years
Considered for Study
1.2.3.
Key
Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1.
Overview
of the Market
3.2.
Overview
of Key Market Segmentations
3.3.
Overview
of Key Market Players
3.4.
Overview
of Key Regions/Countries
3.5.
Overview
of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global
Cell & Gene Therapy Cold Chain Logistics Market Outlook
5.1. Market Size & Forecast
5.1.1.
By
Value
5.2. Market Share & Forecast
5.2.1.
By Component
(Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain
Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits,
Others)
5.2.2.
By
Services Offered (Transportation, Storage, Packaging)
5.2.3.
By
Mode of Transportation (Air, Ground, Water)
5.2.4.
By
Holding Temperature Range (Cryogenic, Refrigerated, Ambient, Others)
5.2.5.
By
End User (Pharmaceutical & Biotechnology Companies, Academic & Research
Institutes, Others)
5.2.6.
By
Region
5.2.7.
By
Company (2023)
5.3. Market Map
6.
North
America Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.1. Market Size & Forecast
6.1.1.
By
Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2.
By
Services Offered
6.2.3.
By
Mode of Transportation
6.2.4.
By
Holding Temperature Range
6.2.5.
By
End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1.
United
States Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By
Component
6.3.1.2.2.
By
Services Offered
6.3.1.2.3.
By
Mode of Transportation
6.3.1.2.4.
By
Holding Temperature Range
6.3.1.2.5.
By
End User
6.3.2.
Canada
Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Component
6.3.2.2.2.
By
Services Offered
6.3.2.2.3.
By
Mode of Transportation
6.3.2.2.4.
By
Holding Temperature Range
6.3.2.2.5.
By
End User
6.3.3.
Mexico
Cell & Gene Therapy Cold Chain Logistics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Component
6.3.3.2.2.
By
Services Offered
6.3.3.2.3.
By
Mode of Transportation
6.3.3.2.4.
By
Holding Temperature Range
6.3.3.2.5.
By
End User
7.
Europe
Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.1. Market Size & Forecast
7.1.1.
By
Value
7.2. Market Share & Forecast
7.2.1.
By
Component
7.2.2.
By
Services Offered
7.2.3.
By
Mode of Transportation
7.2.4.
By
Holding Temperature Range
7.2.5.
By
End User
7.2.6.
By
Country
7.3. Europe: Country Analysis
7.3.1.
Germany
Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Component
7.3.1.2.2.
By
Services Offered
7.3.1.2.3.
By
Mode of Transportation
7.3.1.2.4.
By
Holding Temperature Range
7.3.1.2.5.
By
End User
7.3.2.
United
Kingdom Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Component
7.3.2.2.2.
By
Services Offered
7.3.2.2.3.
By
Mode of Transportation
7.3.2.2.4.
By
Holding Temperature Range
7.3.2.2.5.
By
End User
7.3.3.
Italy
Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecasty
7.3.3.2.1.
By
Component
7.3.3.2.2.
By Services
Offered
7.3.3.2.3.
By
Mode of Transportation
7.3.3.2.4.
By
Holding Temperature Range
7.3.3.2.5.
By
End User
7.3.4.
France
Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Component
7.3.4.2.2.
By
Services Offered
7.3.4.2.3.
By
Mode of Transportation
7.3.4.2.4.
By
Holding Temperature Range
7.3.4.2.5.
By
End User
7.3.5.
Spain
Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Component
7.3.5.2.2.
By
Services Offered
7.3.5.2.3.
By
Mode of Transportation
7.3.5.2.4.
By
Holding Temperature Range
7.3.5.2.5.
By
End User
8.
Asia-Pacific
Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.1. Market Size & Forecast
8.1.1.
By
Value
8.2. Market Share & Forecast
8.2.1.
By
Component
8.2.2.
By
Services Offered
8.2.3.
By
Mode of Transportation
8.2.4.
By
Holding Temperature Range
8.2.5.
By
End User
8.2.6.
By
Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China
Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By
Component
8.3.1.2.2.
By
Services Offered
8.3.1.2.3.
By
Mode of Transportation
8.3.1.2.4.
By
Holding Temperature Range
8.3.1.2.5.
By
End User
8.3.2.
India
Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Component
8.3.2.2.2.
By
Services Offered
8.3.2.2.3.
By
Mode of Transportation
8.3.2.2.4.
By
Holding Temperature Range
8.3.2.2.5.
By
End User
8.3.3.
Japan
Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Component
8.3.3.2.2.
By
Services Offered
8.3.3.2.3.
By
Mode of Transportation
8.3.3.2.4.
By
Holding Temperature Range
8.3.3.2.5.
By
End User
8.3.4.
South
Korea Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By
Component
8.3.4.2.2.
By
Services Offered
8.3.4.2.3.
By
Mode of Transportation
8.3.4.2.4.
By
Holding Temperature Range
8.3.4.2.5.
By
End User
8.3.5.
Australia
Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By
Component
8.3.5.2.2.
By
Services Offered
8.3.5.2.3.
By
Mode of Transportation
8.3.5.2.4.
By
Holding Temperature Range
8.3.5.2.5.
By
End User
9.
South
America Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.1. Market Size & Forecast
9.1.1.
By
Value
9.2. Market Share & Forecast
9.2.1.
By
Component
9.2.2.
By
Services Offered
9.2.3.
By
Mode of Transportation
9.2.4.
By
Holding Temperature Range
9.2.5.
By
End User
9.2.6.
By
Country
9.3. South America: Country Analysis
9.3.1.
Brazil
Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Component
9.3.1.2.2.
By
Services Offered
9.3.1.2.3.
By
Mode of Transportation
9.3.1.2.4.
By
Holding Temperature Range
9.3.1.2.5.
By
End User
9.3.2.
Argentina
Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Component
9.3.2.2.2.
By
Services Offered
9.3.2.2.3.
By
Mode of Transportation
9.3.2.2.4.
By
Holding Temperature Range
9.3.2.2.5.
By
End User
9.3.3.
Colombia
Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Component
9.3.3.2.2.
By
Services Offered
9.3.3.2.3.
By
Mode of Transportation
9.3.3.2.4.
By
Holding Temperature Range
9.3.3.2.5.
By
End User
10. Middle East and Africa Cell & Gene
Therapy Cold Chain Logistics Market Outlook
10.1.
Market
Size & Forecast
10.1.1. By Value
10.2.
Market
Share & Forecast
10.2.1. By Component
10.2.2. By Services Offered
10.2.3. By Mode of Transportation
10.2.4. By Holding Temperature Range
10.2.5. By End User
10.2.6. By Country
10.3.
MEA:
Country Analysis
10.3.1. South Africa Cell & Gene Therapy
Cold Chain Logistics Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By
Component
10.3.1.2.2.
By
Services Offered
10.3.1.2.3.
By
Mode of Transportation
10.3.1.2.4.
By
Holding Temperature Range
10.3.1.2.5.
By
End User
10.3.2. Saudi Arabia Cell & Gene Therapy
Cold Chain Logistics Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By
Component
10.3.2.2.2.
By
Services Offered
10.3.2.2.3.
By
Mode of Transportation
10.3.2.2.4.
By
Holding Temperature Range
10.3.2.2.5.
By
End User
10.3.3. UAE Cell & Gene Therapy Cold Chain
Logistics Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By
Component
10.3.3.2.2.
By
Services Offered
10.3.3.2.3.
By
Mode of Transportation
10.3.3.2.4.
By
Holding Temperature Range
10.3.3.2.5.
By
End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Merger
& Acquisition (If Any)
12.2.
Product
Launches (If Any)
12.3.
Recent
Developments
13. Porter’s Five Forces Analysis
13.1.
Competition
in the Industry
13.2.
Potential
of New Entrants
13.3.
Power
of Suppliers
13.4.
Power
of Customers
13.5.
Threat
of Substitute Products
14. Competitive Landscape
14.1.
Cencora, Inc.
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT
Analysis
14.2.
United Parcel Service, Inc.
14.3.
Catalent, Inc.
14.4.
BioLife Solutions, Inc.
14.5.
Cryoport System LLC.
14.6.
Atelerix Ltd.
14.7.
Life Science Group Ltd (LSG)
14.8.
Yourway Biopharma Services Company
14.9.
Bertelsmann SE & Co. KGaA
14.10.
NMDP BioTherapies
15. Strategic Recommendations
16. About Us & Disclaimer